{"as_of":"2026-08-15T15:50:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:6061bf4cdbd54100b100e2edca6e9ef6d5b240dd6f66475a2c8ef849b11df824","coverage":[{"denominator":21,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":21,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-01T19:33:15.337840Z","state":"measured"},{"denominator":21,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":21,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-15T06:32:42.880941+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2607.16934/citation-record","integrity":"/paper/2607.16934/integrity","json":"/paper/2607.16934/citation-record.json","paper":"/paper/2607.16934"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.196426Z","title":"Assessing the gold standard—lessons from the history of RCTs","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.196426Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:6bfedbf762cab7011902b821eda948ad123738657f6668396835d9847e7575d0","observation_id":"5912fb36-9e12-423d-9dd3-d00090bec8f5","resolution":{"observed_at":"2026-08-01T19:33:14.196426Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.299489Z","title":"Why do we need some large, simple randomized trials? Statistics in medicine","venue":null,"work_id":null,"year":1984},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.299489Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:e1641fd7328d160277dfc320e73b27fa5af8ab48f15d556dcd69a30dbf417acc","observation_id":"9419cd40-ec08-45aa-9300-a1822e7ee147","resolution":{"observed_at":"2026-08-01T19:33:14.299489Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.361954Z","title":"Challenges and lessons learned from COVID-19 trials: should we be doing clinical trials differently? Canadian Journal of Cardiology","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.361954Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:9bd1b9528e58cf77049fb226f1f0e5ef39c454f46dc80a6728c89011bb7c714e","observation_id":"a0aae3da-636f-4e50-86c5-2ab9698be414","resolution":{"observed_at":"2026-08-01T19:33:14.361954Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.422729Z","title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","venue":null,"work_id":null,"year":2015},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.422729Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:42dff2a1d93fda5efe2414f43c9734b12530f4a89d7d4ae999c2427169a7527e","observation_id":"0401a43a-97b1-4392-bf9f-3a4138f6ca03","resolution":{"observed_at":"2026-08-01T19:33:14.422729Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.469361Z","title":"to whom do the results of this trial apply?","venue":null,"work_id":null,"year":2005},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.469361Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:60a000c408b55ea382d99795cc9d4c3dd8b5fa2ed359dded67b2654f647e9445","observation_id":"7768cd28-e600-4f36-87d4-007f83850aec","resolution":{"observed_at":"2026-08-01T19:33:14.469361Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.555368Z","title":"Evaluating eligibility criteria of oncology trials using real-world data and AI","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.555368Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:0612707353d8c9e2dac26a77ff4d291e970d1e650b42a76cd0e57e7b7cec7a73","observation_id":"9b028a4d-561f-4560-a77e-2b8807f97316","resolution":{"observed_at":"2026-08-01T19:33:14.555368Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.622482Z","title":"Broadening eligibility criteria and diversity among patients for cancer clinical trials","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.622482Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:c3d5b21cf90cbd5f5b53e0e05a9bd62130bc62f82abe2645c58ab47ec53259ce","observation_id":"164c73ab-37f2-48ca-8487-281404397311","resolution":{"observed_at":"2026-08-01T19:33:14.622482Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.693533Z","title":"GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.693533Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:c167724834602eec7b62d17d1e1d250adaa196aac33038b7e48565aeac3b1d97","observation_id":"e3664f5e-206a-4756-a373-cbcb657783c6","resolution":{"observed_at":"2026-08-01T19:33:14.693533Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.796079Z","title":"Using big data to emulate a target trial when a randomized trial is not available","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.796079Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:80b80d6e59c6c60e9f3c0b1db3d276a5924a196ea802e5e049389a6c8d1ef665","observation_id":"7bce6f8e-7c0b-4d35-aa19-5c39493d7f66","resolution":{"observed_at":"2026-08-01T19:33:14.796079Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.873003Z","title":"Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.873003Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:a5db667a908ae1c7d7bf73c0f0a824bf53122d5733d43997c36cfbc35eb1195c","observation_id":"da666142-7cb7-4367-970e-4eae026b07f5","resolution":{"observed_at":"2026-08-01T19:33:14.873003Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.929946Z","title":"Real-world evidence and real-world data for evaluating drug safety and effectiveness","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.929946Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:54e495d4dff71970f2be975179731b522a504fbeb7cc0b8ebcb8914ff3b5c0b2","observation_id":"2b5709ee-3562-4e8d-a934-d45b222a504e","resolution":{"observed_at":"2026-08-01T19:33:14.929946Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.990562Z","title":"Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.990562Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:e68e7b02b86dbfd9facf1d229863755f37b216bd7b804fa5522fa59442ace468","observation_id":"9877fbfc-1130-4233-b8a1-61aae5df39e2","resolution":{"observed_at":"2026-08-01T19:33:14.990562Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:14.994029Z","title":"Emulate randomized clinical trials using heterogeneous treatment effect estimation for personalized treatments: Methodology review and benchmark","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:14.994029Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:180f97b51ae3fcc54c35a694a8eb4147bf9f9c2b895be16be5caf56c8cd8ebbc","observation_id":"560960d5-60b8-4d5a-8fee-b8514f925cca","resolution":{"observed_at":"2026-08-01T19:33:14.994029Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.013112Z","title":"Simulating Colorectal Cancer Trials Using Real-World Data","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.013112Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:33c40032855652d3b4ffc3c89cb268f692df758f1bc3fe99451a56b8f54ae597","observation_id":"5358da46-3e74-456b-90d3-79403d7fb5b4","resolution":{"observed_at":"2026-08-01T19:33:15.013112Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.035844Z","title":"Electronic medical records can be used to emulate target trials of sustained treatment strategies","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.035844Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:caef9d2b4f4fc3b350315a32d6e16f38232b12695f3715219ec0b988e972b0e9","observation_id":"afc3ef9d-cbc5-493d-924b-ba2492fc078b","resolution":{"observed_at":"2026-08-01T19:33:15.035844Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.074260Z","title":"Estimation and inference of heterogeneous treatment effects using random forests","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.074260Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:8ebf79721ab7c382c29593ae421b43f02755e05bca704e127d022f39ec03e3fe","observation_id":"198111d6-ae30-4e40-849b-f5aff665f328","resolution":{"observed_at":"2026-08-01T19:33:15.074260Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.108517Z","title":"Metalearners for estimating heterogeneous treatment effects using machine learning","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.108517Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:da20cfe669f9418bb5444874b050bb5a3e0314540ebd95056154a507104c6460","observation_id":"e259e0e3-ad67-4ca3-8798-639fbe2bb091","resolution":{"observed_at":"2026-08-01T19:33:15.108517Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.162966Z","title":"Learning representations for counterfactual inference","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.162966Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:d8d97bfb3df533872192894f8d596675556b1e6b9b1c0a0d26dbc3e5f185e587","observation_id":"7f82336c-c39d-4940-8006-2cd27d0f8562","resolution":{"observed_at":"2026-08-01T19:33:15.162966Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.201993Z","title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.201993Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:27446f4a3aa95903c1d7df9ac9676cff58568d72d10c30a720876a159f8a0665","observation_id":"11d6bcc4-1f1b-46be-a492-d2c92cd0110b","resolution":{"observed_at":"2026-08-01T19:33:15.201993Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.261478Z","title":"Rapid and intensive guideline-directed medical therapy for heart failure: 5 core principles","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.261478Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:f669431b08c5034879b4e3db557fafe55acdbc1a78aa139a126d3f858268b812","observation_id":"ba52d0d3-ff00-4414-8334-436a98b538be","resolution":{"observed_at":"2026-08-01T19:33:15.261478Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-01T19:33:15.337840Z","title":"Machine learning methods for estimating heterogeneous causal effects","venue":null,"work_id":null,"year":2015},"citing_paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-01T19:33:15.337840Z"},"links":{"citing_paper":"/paper/2607.16934"},"observation_digest":"sha256:2d1f362e0ff31cabb6f355db9bc8013b5b81092c527b869e35e21b9476036c23","observation_id":"0606e327-b89d-4b57-815e-fe1980b91c05","resolution":{"observed_at":"2026-08-01T19:33:15.337840Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2607.16934","last_updated":"2026-07-18T19:06:47Z","latest_version":1,"primary_category":"stat.AP","snapshot_observed_at":"2026-08-07T08:46:04.061258Z","submitted_at":"2026-07-18T19:06:47Z","title":"Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects"},"reference_resolution":{"displayed":21,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":21,"verified_exact":0,"verified_fuzzy":0},"total_outbound_references":21},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-15T06:32:42.880941+00:00","source":"crossref"},{"observed_at":"2026-08-15T06:32:39.529945+00:00","source":"retraction_watch"}],"thesis":"As of 15 August 2026, this Paper Citation Record lists 21 of 21 outbound references and 0 inbound Pith citation observations for arXiv:2607.16934."}